BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

721 related articles for article (PubMed ID: 1713741)

  • 1. Expression of c-erbB-2 oncoprotein in mammary and extramammary Paget's disease.
    Wolber RA; Dupuis BA; Wick MR
    Am J Clin Pathol; 1991 Aug; 96(2):243-7. PubMed ID: 1713741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-erbB-2 oncoprotein expression in mammary and extramammary Paget's disease: an immunohistochemical study.
    Keatings L; Sinclair J; Wright C; Corbett IP; Watchorn C; Hennessy C; Angus B; Lennard T; Horne CH
    Histopathology; 1990 Sep; 17(3):243-7. PubMed ID: 2173676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression status of HER2 in mammary and extramammary Paget's disease].
    Meng H; Zheng XY; Zhang L; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):255-6. PubMed ID: 21616001
    [No Abstract]   [Full Text] [Related]  

  • 4. Androgen receptors are frequently expressed in mammary and extramammary Paget's disease.
    Liegl B; Horn LC; Moinfar F
    Mod Pathol; 2005 Oct; 18(10):1283-8. PubMed ID: 15920545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of neu-protein expression in mammary Paget's disease with and without underlying breast carcinoma and in extramammary Paget's disease.
    Meissner K; Rivière A; Haupt G; Löning T
    Am J Pathol; 1990 Dec; 137(6):1305-9. PubMed ID: 1701961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of mucin genes in mammary and extramammary Paget's disease.
    Kuan SF; Montag AG; Hart J; Krausz T; Recant W
    Am J Surg Pathol; 2001 Dec; 25(12):1469-77. PubMed ID: 11717535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraepidermal cytokeratin 7 expression is not restricted to Paget cells but is also seen in Toker cells and Merkel cells.
    Lundquist K; Kohler S; Rouse RV
    Am J Surg Pathol; 1999 Feb; 23(2):212-9. PubMed ID: 9989849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epidermal growth factor receptor 2 expression in extramammary Paget's disease and mammary Paget's disease.
    Jeong SH; Hyeong JH; Park EJ; Kim KJ; Kim KH
    Australas J Dermatol; 2022 Feb; 63(1):115-118. PubMed ID: 34964488
    [No Abstract]   [Full Text] [Related]  

  • 9. Reduced E-cadherin expression correlates with disease progression in Paget's disease of the vulva but not Paget's disease of the breast.
    Ellis PE; Cano SD; Fear M; Kelsell DP; Ghali L; Crow JC; Perrett CW; MacLean AB
    Mod Pathol; 2008 Oct; 21(10):1192-9. PubMed ID: 18469796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of c-erbB-2 oncoprotein expression in extramammary Paget's disease.
    Nishi M; Yoshida H; Setoyama M; Tashiro M
    Dermatology; 1994; 188(2):100-2. PubMed ID: 7907892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammary and extramammary Paget's disease.
    Lloyd J; Flanagan AM
    J Clin Pathol; 2000 Oct; 53(10):742-9. PubMed ID: 11064666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HER2 oncogene amplification in extramammary Paget's disease.
    Tanskanen M; Jahkola T; Asko-Seljavaara S; Jalkanen J; Isola J
    Histopathology; 2003 Jun; 42(6):575-9. PubMed ID: 12786893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Claudins 2, 3, 4, and 5 in Paget's disease and breast carcinoma.
    Soini Y
    Hum Pathol; 2004 Dec; 35(12):1531-6. PubMed ID: 15619213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative immunohistochemical study of mammary and extramammary Paget's disease and superficial spreading melanoma, with particular emphasis on melanocytic markers.
    Ramachandra S; Gillett CE; Millis RR
    Virchows Arch; 1996 Dec; 429(6):371-6. PubMed ID: 8982382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
    Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B
    Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cytokeratin and erbB-2 oncoprotein in Paget's disease of the nipple. An immunohistochemical study.
    Haerslev T; Krag Jacobsen G
    APMIS; 1992 Nov; 100(11):1041-7. PubMed ID: 1282021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammary Paget's disease and extra-mammary Paget's disease: two morphologically similar but biologically different diseases.
    Liu W; Iqbal J; Khoury T
    J Cutan Pathol; 2010 Nov; 37(11):1145-9. PubMed ID: 19719834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing tumour cells of mammary from extramammary Paget's disease using antibodies to two different glycoproteins from human milk-fat-globule membrane.
    Imam A; Yoshida SO; Taylor CR
    Br J Cancer; 1988 Sep; 58(3):373-8. PubMed ID: 2846025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammary and extramammary Paget's disease.
    Sitakalin C; Ackerman AB
    Am J Dermatopathol; 1985 Aug; 7(4):335-40. PubMed ID: 3026195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HER-2/neu expression in Paget disease of the vulva and the female breast.
    Brummer O; Stegner HE; Böhmer G; Kühnle H; Petry KU
    Gynecol Oncol; 2004 Nov; 95(2):336-40. PubMed ID: 15491754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.